Science news

<<  return

 

A "shocking" 80% of individuals in a large Dutch cohort who were eligible for primary prevention with statin therapy reported not taking the drug, a new analysis has shown. Moreover, approximately one in three patients with existing cardiovascular disease also reported forgoing therapy with the LDL-cholesterol-lowering drugs.

This cohort is roughly 240 times smaller than the Dutch population, Balder explained. Based on their findings, the researchers estimate that in 5 years, 12,189 CV events could have been prevented if guideline-recommended statin therapy had been followed.

Balder JW, Scholtens S, Schie LM, et al. Adherence to national guideline in primary and secondary prevention of cardiovascular diseases in the Netherlands: The LifeLines cohort study. ISA 2015; May 24, 2015; Amsterdam, the Netherlands.